Cyclophosphamide Injection, Powder, For Solution
Product Images NDC 68001-443

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cyclophosphamide (NDC 68001-443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cyclophosphamide Structural Formula (Image 01)

Chemical structure of cyclophosphamide, showing the molecular arrangement including a phosphorus atom bonded to oxygen, nitrogen with chlorinated ethyl groups, and a cyclic ether ring.*

FDA Label Image

Cyclophosphamide For Injection 500mg Vial (Image 02)

Label for Cyclophosphamide for Injection, USP 500 mg/vial by BluePoint Laboratories. The sterile, non-pyrogenic powder is for intravenous infusion or direct injection use as a single-dose cytotoxic agent. Instructions for preparation and storage at or below 25°C (77°F) are included. Manufactured by Baxter Healthcare Corporation in Germany.*

FDA Label Image

Cyclophosphamide For Injection 500mg Vial Carton (Image 03)

Packaging label for Cyclophosphamide for Injection, USP, 500 mg/vial by BluePoint Laboratories. The label indicates it is for intravenous infusion or direct injection use and must be diluted. It states the vial contains 500 mg cyclophosphamide USP and includes directions for use, storage instructions, and lot/expiration information. Packaging includes manufacturer details for Baxter Healthcare Corporation.*

FDA Label Image

Cyclophosphamide For Injection 1g Label (Image 05)

Label for Cyclophosphamide for Injection, USP 1 g/vial, sterile powder for intravenous infusion or direct injection. It is labeled as a cytotoxic agent for single-dose use and non-pyrogenic. The label includes preparation instructions, storage conditions, and states it is manufactured by Baxter Healthcare Corporation for BluePoint Laboratories.*

FDA Label Image

Cyclophosphamide For Injection 1g Vial Carton (Image 06)

Cyclophosphamide for Injection, USP 1 g/vial powder for solution label by BluePoint Laboratories. The label indicates the product is for intravenous infusion or direct injection use, and must be diluted. It is a single-dose vial and described as a cytotoxic agent. The label includes manufacturer details (Baxter Healthcare Corporation), storage instructions, dosing notes referring to accompanying literature, and warnings about use.*

FDA Label Image

Cyclophosphamide For Injection 2g Vial Label (Image 08)

Label for Cyclophosphamide for Injection, USP 2 g/vial by BluePoint Laboratories. The label indicates the product is for intravenous infusion or direct injection use, sterile and non-pyrogenic. It includes preparation instructions specifying adding 100 mL of sterile water or 0.9% sodium chloride for injection depending on use. Manufactured by Baxter Healthcare Corporation in Germany.*

FDA Label Image

Cyclophosphamide For Injection 2g Vial Carton (Image 09)

Cyclophosphamide for Injection, USP 2 g/vial powder for solution labeling for intravenous infusion or direct injection use. The label states it is a cytotoxic agent that must be diluted, intended for single-dose vials, and manufactured for BluePoint Laboratories. Storage instructions include keeping the vial at or below 25°C (77°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.